Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Neumora Therapeutics
Biotech
CEPI's founding CEO to lead Wellcome—Chutes & Ladders
Wellcome Trust names a familiar face as CEO. Neumor plucks ex-Amgen development exec to take R&D mantle. Poseida makes CEO swap.
Max Bayer
,
Gabrielle Masson
Oct 13, 2023 9:30am
RayzeBio scores $311M oversized IPO, Neumora hits $250M target
Sep 15, 2023 8:48am
Neumora, RayzeBio seeking more than $200M each in IPOs
Sep 11, 2023 12:13pm
Neumora files for IPO to fund phase 3 depression clinical trials
Aug 28, 2023 9:40am
Stanford president resigns—Chutes & Ladders
Jul 21, 2023 9:30am
Neumora installs new CEO ahead of pivotal depression trials
Jul 18, 2023 6:30am
